Stock MASS 908 DEVICES INC.
Add to a list
To use this feature you must be a member
Log inSign up

News 908 Devices Inc.

Equities

MASS

US65443P1021

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-03 pm EDT 		5-day change 1st Jan Change
5.65 USD -0.35% Intraday chart for 908 Devices Inc. -0.35% -49.64%
Apr. 30 Transcript : 908 Devices Inc., Q1 2024 Earnings Call, Apr 30, 2024
Apr. 30 Earnings Flash (MASS) 908 DEVICES Posts Q1 Revenue $10M MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : 908 Devices Inc., Q1 2024 Earnings Call, Apr 30, 2024
Earnings Flash (MASS) 908 DEVICES Posts Q1 Revenue $10M
MT
908 Devices Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
908 Devices Reports First Quarter 2024 Financial Results and Updates 2024 Revenue Outlook
BU
908 Devices Inc. Provides Revenue Guidance for the Full Year 2024
CI
908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering
BU
908 Devices Inc. acquired CAM2 Technologies, LLC for $76.6 million.
CI
Cam2 Technologies, LLC announced that it has received $45 million in funding from 908 Devices Inc.
CI
908 Devices to Report First Quarter 2024 Financial Results on April 30, 2024
BU
908 Devices Trace Chemical Identification Technology Adopted by European Agencies
BU
908 Devices Inc. Trace Chemical Identification Technology Adopted by European Agencies
CI
Transcript : 908 Devices Inc., Q4 2023 Earnings Call, Mar 05, 2024
908 Devices Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
908 Devices Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Earnings Flash (MASS) 908 DEVICES Reports Q4 Revenue $14.4M
MT
908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue Outlook
BU
908 Devices Inc. Provides Earnings Guidance for the Full Year 2024
CI
North American Morning Briefing : S&P 500 Futures -2-
DJ
908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares' Fully Integrated Cell Therapy Manufacturing Platform
AQ
908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares’ Fully Integrated Cell Therapy Manufacturing Platform
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MASS Stock
  4. News 908 Devices Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW